COMPARISON OF 3 CELL-CYCLE ASSOCIATED ANTIGENS AS MARKERS OF PROLIFERATIVE ACTIVITY AND PROGNOSIS IN BREAST-CARCINOMA

被引:23
|
作者
GILLETT, CE [1 ]
BARNES, DM [1 ]
CAMPLEJOHN, RS [1 ]
机构
[1] ST THOMAS HOSP,DIMBLEBY DEPT CANC RES,LONDON SE1 7EH,ENGLAND
关键词
D O I
10.1136/jcp.46.12.1126
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The staining patterns obtained with two antibodies against proliferating cell nuclear antigen (PC10 and 19A2) and another cell cycle associated antibody (KiS1) were compared with each other and with a number of established prognostic markers of breast carcinoma. Although PC10 and 19A2 staining patterns were similar, only the latter was significantly associated with KiS1 antibody staining. These findings suggest that the two PCNA antibodies detect different epitopes. KiS1 was the only antibody to show an association with S phase fraction measured by flow cytometry (p < 0.001). It was also associated with histological grade (p = 0.003), oestrogen receptors (p = 0.045), and DNA index (p = 0.007). PC10 showed no association with any of the markers of prognosis, while 19A2 was associated with histological grade (p = 0.017) and oestrogen receptors (p = 0.043). The two PCNA antibodies do not seem to be of value in measuring proliferative activity nor do they seem to be associated with established markers of prognosis in breast cancer.
引用
收藏
页码:1126 / 1128
页数:3
相关论文
共 50 条
  • [1] PROLIFERATIVE ACTIVITY IN MUCINOUS BREAST-CARCINOMA
    MCPHAIL, A
    REDDICK, RL
    LABORATORY INVESTIGATION, 1992, 66 (01) : A15 - A15
  • [2] PREDICTION OF BREAST-CARCINOMA RECURRENCE BY BREAST-CARCINOMA ASSOCIATED ANTIGENS (BCAA)
    SALINAS, FA
    CERIANI, RL
    COLDMAN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 186 - 186
  • [3] FLOW CYTOMETRIC CELL-CYCLE ALTERATIONS IN BREAST-CARCINOMA FOLLOWING RADIOTHERAPY
    ZBIERANOWSKI, I
    LERICHE, JC
    JACKSON, SM
    OLIVOTTO, I
    LABORATORY INVESTIGATION, 1991, 64 (01) : A125 - A125
  • [4] PROLIFERATIVE ACTIVITY IS A SIGNIFICANT PROGNOSTIC FACTOR IN MALE BREAST-CARCINOMA
    PICH, A
    MARGARIA, E
    CHIUSA, L
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (02): : 481 - 489
  • [5] CORRELATION OF IMMUNOHISTOCHEMICAL MARKERS WITH PATIENT PROGNOSIS IN BREAST-CARCINOMA - A QUANTITATIVE STUDY
    BARRY, JD
    KOCH, TJ
    COHEN, C
    BRIGATI, DJ
    SHARKEY, FE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 82 (05) : 582 - 585
  • [6] LOSS OF AUTOLOGOUS ANTIBODIES TO BREAST-CARCINOMA ASSOCIATED ANTIGENS IN ADVANCED STAGES
    LEE, YTN
    SHEIKH, KMA
    FRIOU, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 243 - 243
  • [7] BREAST-CARCINOMA ASSOCIATED ANTIGENS (BCAA) - ROLE IN BENIGN AND MALIGNANT BREAST DISEASE (BD)
    SALINAS, FA
    WEE, KH
    CERIANI, RL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 325 - 325
  • [8] Cell-cycle Phase Specific Markers' Expression in Breast Cancer
    Szasz, A.
    Geszti, F.
    Zsakovics, I.
    Szekely, B.
    Tokes, A. M.
    Rowan, A.
    Swanton, C.
    Krenacs, T.
    Kulka, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S143 - S143
  • [9] A Comparison of Cell-Cycle Markers in Skull Base and Sacral Chordomas
    Yakkioui, Youssef
    Temel, Yasin
    Creytens, David
    Jahanshahi, Ali
    Fleischeuer, Ruth
    Santegoeds, Rene G. C.
    Van Overbeeke, Jacobus J.
    WORLD NEUROSURGERY, 2014, 82 (1-2) : E311 - E318
  • [10] Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma
    Krabbe, Laura-Maria
    Margulis, Vitaly
    Lotan, Yair
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (01) : 105 - +